titoli, abstracts, parole chiave >>>
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment

Migliori, Giovanni Battista and Sotgiu, Giovanni and Richardson, Morgan D’Arcy and Centis, Rosella and Günther, Gunar and Hoffmann, Harald and Cirillo, Daniela M. and Toungossova, Olga and Kliiman, Kai and De Lorenzo, Saverio and Spanevello, Antonio and Lange, Christoph (2009) Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment. Clinical Infectious Diseases, Vol. 49 (2), p. 315-316. eISSN 1537-6591. Article.

Full text not available from this repository.

DOI: 10.1086/600060


To the Editor — Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing in frequency globally and are difficult to treat. Although treatment successes have been reported, there are no definitive clinical studies available that show which classes or combinations of available drugs are most effective in yielding positive treatment outcomes.
In the 1 March 2009 issue of Clinical Infectious Diseases, Chan et al. reported that MDR-TB due to strains resistant to fluoroquinolones (FQNs) and streptomycin (STM) but susceptible to second-line injectables (n=12 ) has a significantly better prognosis than does XDR-TB (n=10).

Item Type:Article
ID Code:7888
Uncontrolled Keywords:Multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant TB (XDR-TB)
Subjects:Area 06 - Scienze mediche > MED/01 Statistica medica
Divisions:001 Università di Sassari > 01 Dipartimenti > Scienze biomediche
001 Università di Sassari > 03 Istituti > Igiene e medicina preventiva
Publisher:Oxford University Press
Copyright Holders:© 2009 by the Infectious Diseases Society of America
Deposited On:28 Aug 2012 08:40

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page